"Tumor Escape" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The ability of tumors to evade destruction by the IMMUNE SYSTEM. Theories concerning possible mechanisms by which this takes place involve both cellular immunity (IMMUNITY, CELLULAR) and humoral immunity (ANTIBODY FORMATION), and also costimulatory pathways related to CD28 antigens (CD28 ANTIGENS) and CD80 antigens (B7-1 ANTIGEN).
| Descriptor ID |
D019139
|
| MeSH Number(s) |
G12.900
|
| Concept/Terms |
Tumor Escape- Tumor Escape
- Tumor Immune Evasion
- Evasion, Tumor Immune
- Evasions, Tumor Immune
- Immune Evasions, Tumor
- Tumor Immune Evasions
- Immune Evasion, Tumor
- Immune Escape, Tumor
- Tumor Immune Escape
|
Below are MeSH descriptors whose meaning is more general than "Tumor Escape".
Below are MeSH descriptors whose meaning is more specific than "Tumor Escape".
This graph shows the total number of publications written about "Tumor Escape" by people in this website by year, and whether "Tumor Escape" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2002 | 1 | 1 | 2 |
| 2005 | 1 | 1 | 2 |
| 2006 | 0 | 1 | 1 |
| 2007 | 2 | 2 | 4 |
| 2008 | 3 | 2 | 5 |
| 2009 | 4 | 0 | 4 |
| 2010 | 1 | 1 | 2 |
| 2011 | 2 | 3 | 5 |
| 2012 | 3 | 4 | 7 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 6 | 7 |
| 2015 | 3 | 5 | 8 |
| 2016 | 7 | 2 | 9 |
| 2017 | 2 | 4 | 6 |
| 2018 | 4 | 5 | 9 |
| 2019 | 7 | 10 | 17 |
| 2020 | 6 | 9 | 15 |
| 2021 | 4 | 7 | 11 |
| 2022 | 1 | 1 | 2 |
| 2023 | 1 | 0 | 1 |
| 2024 | 2 | 3 | 5 |
| 2025 | 0 | 1 | 1 |
Below are the most recent publications written about "Tumor Escape" by people in Profiles.
-
Distinct myeloid-derived suppressor cell populations in human glioblastoma. Science. 2025 Jan 17; 387(6731):eabm5214.
-
Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment. Clin Cancer Res. 2024 Dec 02; 30(23):5459-5472.
-
Spatial analysis reveals targetable macrophage-mediated mechanisms of immune evasion in hepatocellular carcinoma minimal residual disease. Nat Cancer. 2024 Oct; 5(10):1534-1556.
-
Current immunotherapy techniques in meningioma. Expert Rev Anticancer Ther. 2024 Oct; 24(10):931-941.
-
Acidity induces durable enhancement of Treg cell suppressive functions for tumor immune evasion. Mol Immunol. 2024 Oct; 174:57-68.
-
Glycosphingolipid synthesis mediates immune evasion in KRAS-driven cancer. Nature. 2024 Sep; 633(8029):451-458.
-
CD47 masks pro-phagocytic ligands in cis on tumor cells to suppress antitumor immunity. Nat Immunol. 2023 Dec; 24(12):2032-2041.
-
SnapShot: Cancer immunoediting. Cell. 2022 10 13; 185(21):4038-4038.e1.
-
Hemangiosarcoma cells induce M2 polarization and PD-L1 expression in macrophages. Sci Rep. 2022 02 08; 12(1):2124.
-
Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma. Nat Commun. 2021 11 26; 12(1):6938.